Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02157883
Title Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | GBR | BEL

Facility Status City State Zip Country Details
Research Site San Diego California 92123 United States Details
Research Site Cleveland Ohio 44106 United States Details
Research Site Edegem 2650 Belgium Details
Research Site Gent 9000 Belgium Details
Research Site lJongno-gu 03080 Korea, Republic of Details
Research Site Seongnam-si 13620 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 05505 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Amsterdam 1066 CX Netherlands Details
Research Site Maastricht 6229 HX Netherlands Details
Research Site Rotterdam 3015 GD Netherlands Details
Research Site Taipei City 11217 Taiwan Details
Research Site Taipei 10002 Taiwan Details
Research Site London SE1 9RT United Kingdom Details
Research Site Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field